Description

PT-141 (Bremelanotide)
PT-141 is a cyclic heptapeptide melanocortin agonist with the sequence Ac-Nle-cyclo(Asp-His-D-Phe-Arg-Trp-Lys)-OH. Unlike other compounds that act via the vascular system, PT-141 is researched for its direct activity on the central nervous system, specifically as a non-selective agonist of melanocortin receptors MC3R and MC4R. It is a primary tool for studying neurological pathways associated with behavioral responses and arousal in animal models.
Molecular Formula: C₅₀H₆₈N₁₄O₁₀
Molecular Weight: 1025.16 g/mol
Form: Lyophilized powder

Research-Only Use: This material is sold strictly for laboratory research use only. It is not intended for human consumption, clinical use, or veterinary applications. No claims are made regarding safety or efficacy for therapeutic purposes.
Disclaimer: The information presented here is provided for scientific and educational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA or any regulatory authority. Product use is restricted to qualified researchers in compliance with local, state, and federal law.
Terms of Sale: By purchasing this item, you confirm that you are a qualified individual or laboratory operating within appropriate research guidelines. All liability and responsibility for handling, use, or misuse of this product rest solely with the buyer.